Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Staphylococcus cell wall is a robust, multi-layered structure essential for bacterial survival, primarily composed of a thick peptidoglycan layer (up to 50% of cell mass) and secondary polymers like wall teichoic acids (WTA) (Swoboda et al., 2010, ChemBioChem). Its fundamental biological role is to maintain cell shape and provide osmotic stability, preventing lysis under high internal pressure (Silhavy et al., 2010, Cold Spring Harbor Perspectives in Biology). Beyond structural support, the cell wall serves as a scaffold for surface proteins (MSCRAMMs) that facilitate adhesion to host tissues and evasion of the immune system during infections (Foster et al., 2014, Nature Reviews Microbiology). Clinically, it is a premier therapeutic target; beta-lactam antibiotics inhibit the transpeptidase enzymes (penicillin-binding proteins) that cross-link peptidoglycan, while glycopeptides like vancomycin bind directly to the D-Ala-D-Ala terminus of precursors to block polymerization (Kohanski et al., 2010, Nature Reviews Microbiology). The evolution of the cell wall—specifically the acquisition of the mecA gene encoding PBP2a—is the primary driver of methicillin resistance (MRSA), making it a focal point of global infectious disease research (Fishovitz et al., 2014, IUBMB Life).
Inhibition of peptidoglycan biosynthesis by binding to penicillin-binding proteins (PBPs) to prevent transpeptidation, or by binding to the D-alanyl-D-alanine terminus of cell wall precursors to inhibit polymerization and cross-linking.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Staphylococcus cell wall.